![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/401 | |
A61P 25/08 |
(11) | Number of the document | 2117535 |
(13) | Kind of document | T |
(96) | European patent application number | 08708027.1 |
Date of filing the European patent application | 2008-01-21 | |
(97) | Date of publication of the European application | 2009-11-18 |
(45) | Date of publication and mention of the grant of the patent | 2011-10-26 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2008/050623 |
Date | 2008-01-21 |
(87) | Number | WO 2008/090116 |
Date | 2008-07-31 |
(30) | Number | Date | Country code |
0701365 | 2007-01-24 | GB |
(72) |
ALVARO, Giuseppe, IT
LARGE, Charles, IT
|
(73) |
Glaxo Group Limited,
Glaxo Wellcome House Berkeley Avenue, Greenford, Middlesex UB6 0NN,
GB
|
(54) | PHARMACEUTICAL COMPOSITIONS COMPRISING NK1 RECEPTOR ANTAGONISTS AND SODIUM CHANNEL BLOCKERS |
PHARMACEUTICAL COMPOSITIONS COMPRISING NK1 RECEPTOR ANTAGONISTS AND SODIUM CHANNEL BLOCKERS |